CV01 ultrasound delivery platform
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CV01 ultrasound delivery platform, covering 2026-02-27 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401) [Phase 1]